1. A3.9 DOT1L, a H3K79 methyltransferase linked to the WNT signallingsignaling cascade, regulates fibrotic responses in lung fibroblasts. (13th February 2015) Authors: Aznar-Lopez, C; De Langhe, E; Monteagudo, S; Cailotto, F; Lories, RJ Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 1 Page Start: A34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P101 DOT1L inhibition increases dermal fibroblast proliferation but has no effects on in vitro or in vivo collagen deposition in models of fibrosis. (21st February 2018) Authors: Berghen, N; De Langhe, E; Lories, R Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 1 Page Start: A56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P110/O18 Epigenetic changes by inhibition of DOT1L affect wnt signaling, proliferation and cell cycle in dermal fibroblasts, with no overall effect on collagen deposition in models of fibrosis. (March 2019) Authors: Berghen, N; Cremer, J; De Langhe, E; Lories, R Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 1 Page Start: A48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pneumocystis jirovecii pneumonia in patients treated for systemic autoimmune disorders: a retrospective analysis of patient characteristics and outcome. (2nd September 2020) Authors: Verhaert, M; Blockmans, D; De Langhe, E; Henckaerts, L Journal: Scandinavian journal of rheumatology Issue: Volume 49:Number 5(2020) Page Start: 345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗